Shoreline Biosciences

Developer of cell-based therapeutic solutions for cancer treatment

placeSan Diego, California, United States calendar_todayFounded 2020 groups98 employees language shorelinebio.com

Innovation

9 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 35 times.

YearFilings
20222
20233
20247
20255

Investor mix

18 investors on record; lead investors include Boxer Capital, Ally Bridge Group.

Investor typeCountShare
Venture capital633%
Private equity422%
Bank & private debt317%
Other / undisclosed528%
Coming soon